Feasibility and Efficacy of a Digital Neurotherapy Protocol for Management of Depression, Cognition, and Quality of Life in Cancer Survivors
- Study HIC#:2000031715
- Last Updated:12/10/2023
This is a prospective, randomized clinical study to evaluate the feasibility and efficacy of a digital neurotherapy on depression, cognition, and quality of life in a sample of cancer survivors.
Contact Us
For more information about this study, including how to volunteer, contact:
Elyssa Noce
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.
Trial Purpose and Description
This is a randomized, waitlist-control study to evaluate the feasibility and efficacy of an 8-week DNT intervention in cancer survivors. Waitlisted subjects will be given the option of receiving the DNT after completion of the waitlist period. Subjects will not be blinded to treatment condition.
Eligibility Criteria
Inclusion criteria
- Provision of signed and date informed consent form.
- Stated willingness to comply with all study procedures and availability for the duration of the study.
- Associated with Smilow Cancer Hospital with a diagnosis for cancer
- Have received chemotherapy, and/or radiation treatment, and/or immunotherapy treatment for cancer
- Aged 18 and older
- Able to understand and read English
Exclusion criteria
- Stage 4 cancer
- Brain cancer
- Diagnosis of serious mental illness (ie, psychosis)
- Cognitive impairment (ie, diagnosed dementia, intellectual development disorder)
- Hearing or vision insufficient to do the computer exercises.
